Eisai Files Alzheimer’s Drug Lecanemab In Europe But Will EMA Grant Fast Track?

Accelerated Assessment Could Cut Months Off Review

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".